Investor Presentaiton
($USD in millions)
INVESTMENT HIGHLIGHTS
2025E LEGAL CANNABIS SPENDING
TOP 15 U.S. MARKETS + OTHER PARALLEL MARKETS 1,2
7,353
5,467
5,000
2,458
1,616
1,547
1,547
High quality assets in
high-growth markets
Blue-chip pedigree
management team
Significant embedded
growth potential
Demonstrated ability to
consolidate
Organizational emphasis
on R&D and innovation
Focused on the fastest growing U.S. markets
Parallel's strong cash position, established infrastructure, and strategic focus on the best markets are expected to facilitate its
position as an industry-leading MSO
Existing market spending
$14.1 billion
'19A-'25E CAGR
32.8%
New market spending
$2.5 billion
'19A-'25E CAGR
69.6%
CA PA FL CO NY AZ IL MA NV MI NJ MD WA OR TX VA GA
1,463
1,363
1,353
1,325
1,312
1,283
1,084
900
815
407
2.6
LEGAL CANNABIS SPENDING GROWTH - 2019A-2025E
EXISTING PARALLEL MARKETS VS. OVERALL U.S. MARKET 1,2
($USD in billions)
+33% CAGR
14.1
12.4
+23% CAGR
1. Market size estimates for Texas assume a full medical-use program, and market size estimates for Florida and Pennsylvania assume full adult-use programs. 2. See "Forward-Looking Statements" disclaimer on pages 3-4 and financial assumptions on pages 57-58.
Sources: Arcview Market Research / BDS Analytics, The State of Legal Cannabis Markets, 8th Edition, Brightfield Group, Virginia JLARC November 2020 report, Company estimates.
21
2019A
2025E
EXISTING PARALLEL MARKETS
2019A
2025E
OVERALL U.S. MARKET
FL NV
MA
PA
☐ TX
42.1
שייView entire presentation